Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Current Medical Research and Opinion|March 17, 2015
Single-pill combination therapy for type 2 diabetes mellitus: linagliptin plus empagliflozinRonnie Aronson
Diabetes Technology & Therapeutics|April 28, 2012
The role of comfort and discomfort in insulin therapyRonnie Aronson
Expert Review of Clinical Pharmacology|October 24, 2013
Optimizing glycemic control: lixisenatide and basal insulin in combination therapy for the treatment of Type 2 diabetes mellitusRonnie Aronson
Expert Opinion on Pharmacotherapy|May 17, 2012
Combination therapy in type 2 diabetes mellitus: adding linagliptin to a stable regimen of metformin and a sulfonylureaRonnie Aronson
Diabetes Technology & Therapeutics|August 23, 2017
Effect of Dapagliflozin on Glycemic Control, Weight, and Blood Pressure in Patients with Type 2 Diabetes Attending a Specialist Endocrinology Practice in Canada: A Retrospective Cohort AnalysisRuth E Brown, Nikhil Gupta, Ronnie Aronson
Diabetes, Obesity & Metabolism|April 3, 2019
First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetesRonnie Aronson, Alexander Abitbol, Katherine S Tweden
Diabetes, Obesity & Metabolism|June 16, 2020
Semaglutide once weekly in people with type 2 diabetes: Real-world analysis of the Canadian LMC diabetes registry (SPARE study)Ruth E Brown, Peter G Bech, Ronnie Aronson
Diabetes, Obesity & Metabolism|November 14, 2018
Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemiaRonnie Aronson, Guillermo Umpierrez, William Stager, et al.
Canadian Journal of Diabetes|February 14, 2021
Prevalence and Risk Evaluation of Diabetic Complications of the Foot Among Adults With Type 1 and Type 2 Diabetes in a Large Canadian Population (PEDAL Study)Ronnie Aronson, Lisa Chu, Nicole Joseph, et al.
Diabetes Technology & Therapeutics|September 23, 2016
Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE Trial)Harpreet S Bajaj, Karri Venn, Chenglin Ye, et al.
Pageof 7